Read + Share
Khan SU, Yedlapati SH, Lone AN, Hao Q, et al. PCSK9 inhibitors and ezetimibe with or without statin therapy for cardiovascular
risk reduction: a systematic review and network meta-analysis. BMJ 2022;377:e069116.
PMID: 35508321
|
 |
|
Khan SU, Yedlapati SH, Lone AN, Hao Q, et al. PCSK9 inhibitors and ezetimibe with or without statin therapy for cardiovascular
risk reduction: a systematic review and network meta-analysis. BMJ 2022;377:e069116.
PMID: 35508321
|
|
|
|